Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired |
gptkb:Novartis_Vaccines_and_Diagnostics
|
| gptkbp:collaborates_with |
health organizations
|
| gptkbp:complies_with |
gptkb:regulations
|
| gptkbp:employs |
over 1,000 people
|
| gptkbp:founded |
gptkb:2015
|
| gptkbp:has_part |
gptkb:Afluria
Fluzone Afluria High-Dose Quadrivalent Afluria High-Dose Senior Afluria Quad Afluria Quadrivalent Flu Mist Flu Mist High-Dose Quadrivalent Flu Mist High-Dose Senior Flu Mist Quadrivalent Flu Zone High-Dose Quadrivalent Flu Zone High-Dose Senior Flu Zone Quadrivalent Fluad Fluad High-Dose Quadrivalent Fluad High-Dose Senior Fluad Pediatric Fluad Quad Fluad Quadrivalent High-Dose Fluad Quadrivalent Pediatric Fluad Quadrivalent Senior Fluad Senior Fluvirin Fluvirin High-Dose Quadrivalent Fluvirin High-Dose Senior Fluvirin Quadrivalent Fluzone High-Dose Seqirus QIV |
| gptkbp:headquarters |
gptkb:Parkville,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
CSL Seqirus
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:offers |
influenza vaccines
|
| gptkbp:operates_in |
global market
|
| gptkbp:parent_company |
gptkb:CSL_Limited
|
| gptkbp:research_focus |
vaccine development
|
| gptkbp:specializes_in |
vaccines
|
| gptkbp:subsidiary |
Seqirus Australia
Seqirus Canada Seqirus UK Seqirus USA |
| gptkbp:bfsParent |
gptkb:CSL_Limited
|
| gptkbp:bfsLayer |
6
|